RAEM Tollenaar

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
To answer research questions concerning the course of disease and the optimal treatment of hereditary breast cancer, genetic typing together with the clinical and tumour characteristics of breast cancer patients are an important source of information. Part of the incidence of breast cancer can be explained by BRCA1 and BRCA2 germline mutations, which with(More)
10558 Background: We have recently shown that a single nucleotide polymorphism (SNP) in WT1 exon 7 (rs16754) is associated with prognosis in patients with acute myeloid leukemia. To test whether SNP rs16754 is also associated with outcome in other cancers, we investigated the role of this SNP as a candidate polymorphism for breast cancer (BC) survival in a(More)
  • 1